Rare paediatric disease priority review, page-31

Maybe they pay them more because they are the last ones, apparently from September 30, 2024 they will not give them anymore:

2024 update: Rare Pediatric Disease PRV program sunset

Under the current provisions in the law, the rare pediatric disease PRV program will begin to sunset after September 30, 2024. Section 529(b)(5) of the Federal Food, Drug, and Cosmetic Act states:

• (5) TERMINATION OF AUTHORITY.—The Secretary may not award any priority review vouchers [. . .] after September 30, 2024, unless the rare pediatric disease product application—
  • (A) is for a drug that, not later than September 30, 2024, is designated [. . .] as a drug for a rare pediatric disease; and
  • (B) is, not later than September 30, 2026, approved under section 505(b)(1) of this Act or section 351(a) of the Public Health Service Act.

tps://www.fda.gov/industry/medical-products-rare-diseases-and-conditions/rare-pediatric-disease-designation-and-priority-review-voucher-programs#:~:text=Under%20this%20voucher%20program%2C%20a,the%20voucher%20to%20another%20sponsor.


If only Acadia was so good that it hasn't sold yet!!!